AISight Dx
by PathAI
AISight Dx is PathAI's digital pathology platform and image management system for pathology laboratories and academic centres. The vendor says pathologists use it to view, interpret, share and manage whole-slide images, and that AI runs inside the slide viewer: PathAI's own workflow algorithms for quality control, prioritising cases in which suspicious tissue is found and assessing tumour cellularity before sequencing, plus more than 40 third-party algorithms, for example for PD-L1, HER2, Ki-67 and other biomarkers, each with its own regulatory status. The vendor says its automated case review, assisted diagnosis, reporting and finalisation features are research-use only and not for primary diagnosis, so the diagnosis stays with the pathologist reading the slides. It describes the platform as cloud-native, and for a European deployment announced in 2025 says all data storage and processing remain within Europe; its general privacy notice says its platforms are operated and hosted from the United States.
Transparency Score
Weighted across four pillars · updated October 20, 2026
Capabilities
Vendor Information
Complete information about the vendor/provider of this AI application
EU AI Act Provider Information
Potential Risks
1 considerations identified
Review recommended before use
These considerations are automatically identified based on publicly available information about the vendor and AI catalog data. Actual risks may vary based on your specific use case and implementation.
Get insights into risk by running assessments on this AI application.
Work at PathAI? Claim this listing to correct or complete the data.
Ready to manage AI applications?
Track, assess, and govern your AI applications with Anove.